SCHEDULE: Evogene Ltd. Stakeholder Increases Ownership to 16.81%

L.I.A. Pure Capital Ltd. and affiliated entities have increased their beneficial ownership in Evogene Ltd. to 16.81% through open market purchases of American Depositary Shares.

Summary

• L.I.A. Pure Capital Ltd. (Pure Capital) and its affiliates, including Invest Pro Shukai Hon Ltd. (Invest Pro), have filed an amendment to their Schedule 13D, reporting an increase in their beneficial ownership of Evogene Ltd. ordinary shares and ADSs.
• The total beneficial ownership now stands at 2,228,100 securities, representing approximately 16.81% of Evogene Ltd.'s outstanding shares as of July 17, 2026.
• This increase is due to additional purchases of American Depositary Shares (ADSs) by Pure Capital, acquired using working capital.
• Kfir Silberman is the controlling shareholder of Pure Capital, and Ron Yair Peled is the owner and CEO of Invest Pro. Both may be deemed beneficial owners of the securities held by their respective entities.
• The reporting persons may be considered a 'group' for the purposes of Section 13(d) of the Exchange Act, though they disclaim the existence of such a group.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this filing as neutral, primarily reporting on increased ownership without providing new operational or financial performance data for Evogene Ltd. itself.

Positives

• Increased beneficial ownership by significant stakeholders, indicating confidence in the company.
• Acquisition of shares was conducted through open market purchases, suggesting organic investment.
• The reporting persons have a substantial stake of 16.81%, which could lead to increased engagement with the company's strategic direction.

Negatives

• The exact total number of outstanding ordinary shares is not disclosed, making the precise percentage ownership potentially lower than reported.
• The filing does not provide details on the specific strategic intentions behind the increased ownership, beyond general beneficial ownership reporting.

Risks

• Potential for increased scrutiny from regulators or other shareholders regarding the formation of a 'group' for beneficial ownership purposes.
• Uncertainty regarding the actual total number of outstanding shares could lead to misinterpretation of ownership percentages.

Future Outlook

The filing does not contain specific forward-looking statements or guidance from Evogene Ltd. It primarily reports on changes in beneficial ownership by certain investors.

Management Comments

• The reporting persons may be deemed to constitute a 'group' for purposes of Section 13(d) of the Exchange Act.
• Each Reporting Person specifically disclaims beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein.
• Neither the filing of this Schedule 13D nor any of its contents shall be deemed to constitute an admission that a group exists for purposes of Schedule 13(d) of the Exchange Act or for any other purpose.

Industry Context

StockSavvy.ai notes that increased beneficial ownership filings like this Schedule 13D amendment are common in the biotechnology and agricultural technology sectors, often signaling a strategic interest or potential for activist involvement by significant investors.

Stakeholder Impact

• Shareholders: Potential for increased volatility or strategic shifts in the company's direction due to concentrated ownership.
• Management: May face increased pressure or engagement from the reporting persons regarding corporate strategy and governance.
• Creditors: No immediate impact indicated, as the filing focuses on equity ownership.

Next Steps

• Monitoring of further purchases or disclosures by L.I.A. Pure Capital Ltd. and its affiliates.
• Observation of Evogene Ltd.'s strategic responses, if any, to the increased stakeholder interest.

Key Dates

Keywords

Evogene Ltd., Schedule 13D, Beneficial Ownership, L.I.A. Pure Capital Ltd., Kfir Silberman, American Depositary Shares, Ordinary Shares, SEC Filing